Osteoporosis: Starting Anti-Osteoporosis Therapy — free guideline decision tool
[Pending update] Some thresholds, grades and management recommendations on this page that conflict with current guidelines or are unverified are temporarily hidden pending verification against the guideline text.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Hip or vertebral fragility-fracture history | Present |
|---|---|
| Fragility fracture at other sites | Present |
| BMD T-score (lowest site) | -2.7 |
| FRAX 10-year major osteoporotic fracture probability (optional) | 22 % |
| FRAX 10-year hip fracture probability (optional) | 3.5 % |
→DispositionImmediately start anti-osteoporosis treatment
- Diagnosis：Osteoporosis (hip/vertebral fragility fracture; diagnosable without BMD)
- Fracture risk：Very high
- Drug direction：[Pending update] Some thresholds, grades and management recommendations on this page that conflict with current guidelines or are unverified are temporarily hidden pending verification against the guideline text.
| Hip or vertebral fragility-fracture history | Absent |
|---|---|
| Fragility fracture at other sites | Absent |
| BMD T-score (lowest site) | -2.7 |
| FRAX 10-year major osteoporotic fracture probability (optional) | 22 % |
| FRAX 10-year hip fracture probability (optional) | 3.5 % |
→DispositionRecommend anti-osteoporosis treatment
- Diagnosis：Osteoporosis (T-score ≤ -2.5)
- Fracture risk：High
- Drug direction：High fracture risk: oral alendronate/risedronate etc.
Common questions
What is Osteoporosis: Starting Anti-Osteoporosis Therapy?
[Pending update] Some thresholds, grades and management recommendations on this page that conflict with current guidelines or are unverified are temporarily hidden pending verification against the guideline text.
How is Osteoporosis: Starting Anti-Osteoporosis Therapy calculated? What is the core formula?
[Pending update] Some thresholds, grades and management recommendations on this page that conflict with current guidelines or are unverified are temporarily hidden pending verification against the guideline text.
When is Osteoporosis: Starting Anti-Osteoporosis Therapy used?
[Pending update] Some thresholds, grades and management recommendations on this page that conflict with current guidelines or are unverified are temporarily hidden pending verification against the guideline text.
What are the key clinical points for Osteoporosis: Starting Anti-Osteoporosis Therapy?
A hip or vertebral fragility fracture diagnoses osteoporosis and triggers treatment independent of the BMD value. (original synthesis · not guideline verbatim) All patients receive calcium, vitamin D, weight-bearing exercise, fall prevention, and a secondary-cause workup.
What are the limits and cautions when using Osteoporosis: Starting Anti-Osteoporosis Therapy?
For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
Does Osteoporosis: Starting Anti-Osteoporosis Therapy upload patient data? Where is it calculated?
Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
How is Osteoporosis: Starting Anti-Osteoporosis Therapy calculated in practice? Can you show a worked example?
Inputs: Hip or vertebral fragility-fracture history Present, Fragility fracture at other sites Present, BMD T-score (lowest site) -2.7, FRAX 10-year major osteoporotic fracture probability (optional) 22 %, FRAX 10-year hip fracture probability (optional) 3.5 % → Result: Disposition Immediately start anti-osteoporosis treatment（Diagnosis: Osteoporosis (hip/vertebral fragility fracture; diagnosable without BMD), Fracture risk: Very high, Drug direction: [Pending update] Some thresholds, grades and management recommendations on this page that conflict with current guidelines or are unverified are temporarily hidden pending verification against the guideline text.） Inputs: Hip or vertebral fragility-fracture history Absent, Fragility fracture at other sites Absent, BMD T-score (lowest site) -2.7, FRAX 10-year major osteoporotic fracture probability (optional) 22 %, FRAX 10-year hip fracture probability (optional) 3.5 % → Result: Disposition Recommend anti-osteoporosis treatment（Diagnosis: Osteoporosis (T-score ≤ -2.5), Fracture risk: High, Drug direction: High fracture risk: oral alendronate/risedronate etc.）
Run Osteoporosis: Starting Anti-Osteoporosis Therapy now
[Pending update] Some thresholds, grades and management recommendations on this page that conflict with current guidelines or are unverified are temporarily hidden pending verification against the guideline text.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.